Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion type Assertion NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_head.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion wasGeneratedBy ECO_0000203 NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_provenance.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion wasDerivedFrom befree-20140225 NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_provenance.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion SIO_000772 15162063 NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_provenance.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion evidence source_evidence_literature NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_provenance.
- NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_assertion description "[Therefore, increased frequencies of ETV6/RUNX1 fusions in ALL cured patients indicate the influence of previous exposure to anti-cancer drugs, and they may represent an important genetic marker for estimating the risk of relapse, or development of secondary neoplasias.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219281.RAFVzsTOdDPzueBnjUpThjHawfEQvH18C9urDtIyKpNk8130_provenance.